申请人:The Upjohn Company
公开号:US04044148A1
公开(公告)日:1977-08-23
It has now been discovered that novel compounds of Formula 1 are useful in the prophylactic treatment of sensitized humans and animals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature. Additionally, the compounds are formulated with pharmaceutical carriers for oral, parenteral, inhalation, or rectal means of administration.
现在已经发现,公式1的新化合物在预防治疗敏感人和动物对过敏和所有抗原或非抗原介导的过敏反应中是有用的。此外,这些化合物与药物载体配制,可通过口服、注射、吸入或直肠途径进行给药。